the potential of stromal vascular fraction (SVF)
cell therapy as a novel regenerative treatment for ICH. SVF
Timasheva, Yanina,
Kochetova, Olga,
Balkhiyarova, Zhanna,
Korytina, Gulnaz,
Prokopenko, Inga,
Nouwen, Arie (2025) , neurotransmitters, and β-
cell function, to develop a prognostic tool for MetS risk. Methods: We genotyped 40 genetic
of the disease is associated with an impact on genes and signaling pathways regulating
cell proliferation
Beylerli, Ozal,
Gareev, Ilgiz,
Musaev, Elmar,
Roumiantsev, Sergey,
Chekhonin, Vladimir,
Ahmad, Aamir,
Chao, Yuan,
Yang, Guang (2025) /MEK/ERK pathway inhibitors, IDH mutation inhibitors, immune checkpoint inhibitors, and CAR-T
cell therapies
Bikbov, Mukharram M.,
Kazakbaeva, Gyulli M.,
Rakhimova, Ellina M.,
Panda-Jonas, Songhomitra,
Tuliakova, Azaliia M.,
Fakhretdinova, Albina A.,
Jonas, Jost B. (2025) (OR: 2.25), history of
cancer (OR: 1.93) and dementia (OR: 2.54), higher serum concentration